SCHEMBL20107968

SCHEMBL20107968

N#Cc1cc(F)c(Br)cc1OCC(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 10/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
G6PD P11413 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TRPV4 Q9HBA0 1/20 0.36
PGR P06401 1/20 0.34
AAK1 Q2M2I8 4/20 0.34
CACNA1H O95180 1/20 0.34
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23862114 0.88 AAK1 (0.37) ARTRPV4AAK1
SCHEMBL3288183 0.87 ALDH1A1 (0.43) ARKDM4EMEN1USP2ALDH1A1
SCHEMBL27427354 0.81 CYP11B1 (0.42) ARKDM4EMAPTHSD17B10TRPV4
SCHEMBL20108197 0.79 AAK1 (0.44) ARKDM4EMEN1USP2ALDH1A1
SCHEMBL3746625 0.78 FFAR1 (0.49) ARKDM4EMEN1USP2ALDH1A1
SCHEMBL20107668 0.77 ALDH1A1 (0.44) ARALDH1A1
SCHEMBL12128120 0.76 AAK1 (0.49) ARKDM4EMEN1USP2ALDH1A1
SCHEMBL21463047 0.76 DHODH (0.37) ARS1PR1S1PR3S1PR5
SCHEMBL20107965 0.76 DHODH (0.37) ARS1PR1S1PR3S1PR5
SCHEMBL29512855 0.76 DHODH (0.37) ARS1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3532468-B1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AG (DE) 2022-03-23 EP disclosed
WO-2019197269-A1 COMBINATIONS OF COPANLISIB WITH TRIAZOLONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2019-10-17 WO disclosed
EP-3553052-A1 5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL DERIVATIVES FOR THE TREATMENT OF CANCER Bayer AG (DE) 2019-10-16 EP disclosed
WO-2018077944-A2 4,5-ANNULATED 1,2,4-TRIAZOLONES BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed
WO-2018077923-A1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed